The Relation of Anxiety and Cognition in Parkinson’s Disease
暂无分享,去创建一个
G. Reynolds | A. Cronin-Golomb | Sandy A. Neargarder | Sandy Neargarder | Alice Cronin-Golomb | Gretchen O. Reynolds | Kristine K. Hanna | K. K. Hanna
[1] Thomas Foltynie,et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.
[2] A. Cronin-Golomb,et al. Impact of Anxiety on Quality of Life in Parkinson's Disease , 2011, Parkinson's disease.
[3] R. Barker,et al. Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms , 2014, Movement disorders : official journal of the Movement Disorder Society.
[4] B. Pollock,et al. Comorbid anxiety disorder in late life depression: association with memory decline over four years , 2005, International journal of geriatric psychiatry.
[5] L. Friberg,et al. Cognitive impairment in early‐stage non‐demented Parkinson's disease patients , 2014, Acta neurologica Scandinavica.
[6] R C Grace,et al. A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia. , 2008, Parkinsonism & related disorders.
[7] M. Millan,et al. The neurobiology and control of anxious states , 2003, Progress in Neurobiology.
[8] K. Marder,et al. Memory and executive function impairment predict dementia in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[9] N. Narayanan,et al. Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease , 2013, Reviews in the neurosciences.
[10] H. Braak,et al. Dysfunction of the locus coeruleus–norepinephrine system and related circuitry in Parkinson's disease-related dementia , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[11] A. Cronin-Golomb. Emergence of nonmotor symptoms as the focus of research and treatment of Parkinson's disease: introduction to the special section on nonmotor dysfunctions in Parkinson's disease. , 2013, Behavioral neuroscience.
[12] D. Aarsland,et al. Mild Cognitive Impairment in Parkinson’s Disease , 2011, Current neurology and neuroscience reports.
[13] T. Robbins,et al. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. , 2001, Cerebral cortex.
[14] K. Dujardin,et al. The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale , 2014, Movement disorders : official journal of the Movement Disorder Society.
[15] T. Robbins,et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.
[16] D. Aarsland,et al. Neuropsychiatric Symptoms in Parkinson's Disease. , 2015, Journal of Parkinson's disease.
[17] Q. Almeida,et al. Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory–perceptual processing while walking , 2015, Neuropsychologia.
[18] J. Wetherell,et al. Cognitive errors, symptom severity, and response to cognitive behavior therapy in older adults with generalized anxiety disorder. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[19] K. Dujardin,et al. Anxiety rating scales in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.
[20] M. Schwarzbold,et al. Anxiety in Parkinson’s disease: A critical review of experimental and clinical studies , 2012, Neuropharmacology.
[21] Mariusz S Wiglusz,et al. Prevalence of anxiety disorders in epilepsy , 2018, Epilepsy & Behavior.
[22] J. Galvin. Cognitive Change in Parkinson Disease , 2006, Alzheimer disease and associated disorders.
[23] Maria Larsson,et al. Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction. , 2005, Journal of psychiatric research.
[24] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[25] H. Mayberg,et al. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[26] P. Martínez-Martín,et al. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease. , 2008, Parkinsonism & related disorders.
[27] M. Ceccaldi,et al. Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling , 2002, Neurology.
[28] R. Petersen,et al. Mild cognitive impairment , 2006, The Lancet.
[29] K. Walsh,et al. Parkinson's disease and anxiety , 2001, Postgraduate medical journal.
[30] P. Silburn,et al. Anxiety disorders in Parkinson's disease: Prevalence and risk factors , 2010, Movement disorders : official journal of the Movement Disorder Society.
[31] Y. Agid,et al. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.
[32] L. Fratiglioni,et al. Psychiatric symptoms/syndromes in elderly persons with mild cognitive impairment. Data from a cross‐sectional study , 2003, Acta neurologica Scandinavica. Supplementum.
[33] P. Rabins,et al. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[34] J. Obeso,et al. Pathophysiology of the basal ganglia in Parkinson's disease , 2000, Trends in Neurosciences.
[35] S. Lewis,et al. Anxiety is associated with freezing of gait and attentional set-shifting in Parkinson's disease: A new perspective for early intervention. , 2016, Gait & posture.
[36] Jane S. Paulsen,et al. The Trail Making Test in prodromal Huntington disease: Contributions of disease progression to test performance , 2011, Journal of clinical and experimental neuropsychology.
[37] A. Tröster,et al. Which symptoms of anxiety diminish after surgical interventions for Parkinson disease? , 1999, Neuropsychiatry, neuropsychology, and behavioral neurology.
[38] M. Eysenck,et al. Anxiety and cognitive performance: attentional control theory. , 2007, Emotion.
[39] Megan M. Risi,et al. Frontal and posterior subtypes of neuropsychological deficit in Parkinson's disease. , 2013, Behavioral neuroscience.
[40] C. Stern,et al. The Basal Ganglia and Decision-Making in Neuropsychiatric Disorders , 2016 .
[41] R. O'Hara,et al. The association of anxiety and depressive symptoms with cognitive performance in community-dwelling older adults. , 2009, Psychology and aging.
[42] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[43] B. Schmand,et al. Cognitive profile of patients with newly diagnosed Parkinson disease , 2005, Neurology.
[44] K. Dujardin,et al. Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale , 2011, Movement disorders : official journal of the Movement Disorder Society.
[45] B. Mulsant,et al. Cognitive impairment in late-life generalized anxiety disorder. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[46] T. Tombaugh. Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[47] D. Aarsland,et al. A systematic review of prevalence studies of depression in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[48] K. Bayles,et al. A longitudinal study of neuropsychological change in individuals with Parkinson's disease , 2003, International journal of geriatric psychiatry.
[49] M. Eysenck,et al. Anxiety, Processing Efficiency, and Cognitive Performance New Developments from Attentional Control Theory , 2009 .
[50] K. Ressler,et al. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders , 2000, Depression and anxiety.
[51] C. Clarke,et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[52] R. Brown,et al. Apathy in Parkinson’s disease , 2002, Journal of neurology, neurosurgery, and psychiatry.
[53] C. Adler,et al. The neurobiological basis of cognitive impairment in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.
[54] U. Bonuccelli,et al. Affective symptoms and cognitive functions in Parkinson's disease , 2012, Journal of the Neurological Sciences.
[55] Angie A. Kehagia,et al. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease , 2010, The Lancet Neurology.
[56] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[57] M. Butters,et al. Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorder , 2011, British Journal of Psychiatry.
[58] C. Tanner,et al. Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. , 2009, Parkinsonism & related disorders.
[59] Richard Mayeux,et al. Epidemiology of neurodegeneration. , 2003, Annual review of neuroscience.
[60] A. Cronin-Golomb,et al. Neurocognitive Correlates of Apathy and Anxiety in Parkinson's Disease , 2011, Parkinson's disease.
[61] N. S. Miller,et al. Psychiatric Comorbidity , 1994, Alcohol health and research world.
[62] P. Barone,et al. Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia , 2009, Journal of Neurology.
[63] I. Daum,et al. Depressed mood and executive dysfunction in early Parkinson's disease , 2003, Acta neurologica Scandinavica.
[64] S. Papapetropoulos,et al. Psychiatric comorbidity in a population of Parkinson's disease patients , 2006, European journal of neurology.
[65] A. Cronin-Golomb,et al. Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson's Disease , 2012, Parkinson's disease.
[66] R. L. Greene,et al. Changes in neuropsychological functioning in an aging population. , 1980, Journal of consulting and clinical psychology.
[67] Hansjürgen Bratzke,et al. Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.
[68] G. Ganis,et al. Frontostriatal circuits are necessary for visuomotor transformation: Mental rotation in Parkinson's disease , 2006, Neuropsychologia.
[69] J. Groothoff,et al. The impact of sleep and mood disorders on quality of life in Parkinson’s disease patients , 2011, Journal of Neurology.
[70] Angie A. Kehagia,et al. Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation , 2010, Current Opinion in Neurobiology.
[71] Manuel Rodríguez,et al. The basal ganglia and disorders of movement: pathophysiological mechanisms. , 2002, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[72] Daniel Weintraub,et al. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. , 2009, Parkinsonism & related disorders.
[73] M. Jahanshahi,et al. Executive dysfunction in Parkinson's disease: a review. , 2013, Journal of neuropsychology.
[74] A. Cronin-Golomb,et al. Alexithymia and Apathy in Parkinson’s Disease: Neurocognitive Correlates , 2013, Behavioural neurology.
[75] W. Weiner,et al. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. , 2002, Parkinsonism & related disorders.
[76] W. Weiner,et al. Comorbidity of the nonmotor symptoms of Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.
[77] A. Cronin-Golomb,et al. The impact of motor symptoms on self-reported anxiety in Parkinson's disease. , 2017, Parkinsonism & related disorders.
[78] Stephanie L. Alberico,et al. The Vulnerable Ventral Tegmental Area in Parkinson's Disease. , 2015, Basal ganglia.
[79] D R Rajput,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[80] Roshan Cools,et al. Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson's disease , 2009, Neuropsychologia.
[81] Kurt Jellinger,et al. Amygdala pathology in Parkinson's disease , 2004, Acta Neuropathologica.
[82] P. Werner,et al. Anxiety disorder and accompanying subjective memory loss in the elderly as a predictor of future cognitive decline , 2003, International journal of geriatric psychiatry.
[83] Matthew A. Menza,et al. Parkinson's disease and anxiety: Comorbidity with depression , 1993, Biological Psychiatry.
[84] K. Dujardin,et al. Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study , 2011, Movement disorders : official journal of the Movement Disorder Society.
[85] Katherine J. Jones,et al. Predictors of Mild Cognitive Impairment in Early-Stage Parkinson's Disease , 2013, Dementia and Geriatric Cognitive Disorders Extra.